Skip to content

Drug interactions

Repaglinide + Tucatinib

Severity: Moderate

Repaglinide and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and can raise repaglinide exposure. Higher repaglinide levels increase the risk of prolonged or severe hypoglycemia.

What this interaction means in plain words

Repaglinide and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Repaglinide belongs to Endocrine; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4, reducing part of repaglinide's oxidative metabolism (CYP2C8 is its main route).

What to do

Monitor blood glucose closely when starting or stopping tucatinib and reduce the repaglinide dose if hypoglycemia occurs. Consider an alternative antidiabetic agent if glucose control becomes unstable.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Repaglinide and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Repaglinide with Tucatinib?

MediHelp rates the interaction as moderate. Repaglinide and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A4 and can raise repaglinide exposure. Higher repaglinide levels increase the risk of prolonged or severe hypoglycemia.

How serious is the interaction between Repaglinide and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting or stopping tucatinib and reduce the repaglinide dose if hypoglycemia occurs. Consider an alternative antidiabetic agent if glucose control becomes unstable.

What other medicines interact with Repaglinide?

MediHelp also lists interactions of Repaglinide with, for example, Gemfibrozil, Clarithromycin, Clopidogrel. The full list is on the Repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in